Neximmune Inc
General ticker "NEXI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $397.3K
Neximmune Inc does not follow the US Stock Market performance with the rate: -42.0%.
Estimated limits based on current volatility of 11.0%: low 0.23$, high 0.28$
Factors to consider:
- Current price 79.0% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [3.00$, 13.07$]
- 2023-12-31 to 2024-12-30 estimated range: [1.33$, 5.55$]
Short-term NEXI quotes
Long-term NEXI plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $27.85MM | $53.26MM | $63.08MM |
| Operating Income | $-27.85MM | $-53.26MM | $-63.08MM |
| Non-Operating Income | $-2.01MM | $2.35MM | $0.58MM |
| Interest Expense | $1.68MM | $0.91MM | $0.00MM |
| R&D Expense | $17.84MM | $37.46MM | $47.15MM |
| Income(Loss) | $-29.87MM | $-50.90MM | $-62.51MM |
| Profit(Loss) | $-29.87MM | $-50.90MM | $-62.51MM |
| Stockholders Equity | $-69.37MM | $83.76MM | $32.30MM |
| Inventory | $0.00MM | $0.00MM | $0.02MM |
| Assets | $11.30MM | $91.03MM | $43.06MM |
| Operating Cash Flow | $-26.40MM | $-45.79MM | $-51.19MM |
| Capital expenditure | $0.86MM | $2.35MM | $1.26MM |
| Investing Cash Flow | $0.22MM | $-53.81MM | $50.32MM |
| Financing Cash Flow | $22.08MM | $124.89MM | $5.18MM |
| Earnings Per Share* | $-34.76 | $-56.67 | $-534.29 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.